CLINICAL_TRIALS
research
· 2026-02-19
Clinical Trial Update: CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy [NA]
Summary
A University of Texas at Austin study investigates CO2 reactivity as a biomarker for non-response to exposure-based therapy across multiple anxiety disorders an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas at Austin | Conditions: Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder | NA | Status: RECRUITING